TI
SGMO

Trexquant Investment’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Trexquant Investment’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-148,502
Closed -$1.4M – 1443
2020
Q3 		$1.4M Buy
148,502
+95,975
+183% +$1.04M 0.09% 309
2020
Q2 		$471K Buy
+52,527
New +$487K 0.03% 702
2019
Q2 		– Sell
-10,392
Closed -$99K – 1081
2019
Q1 		$99K Sell
10,392
-64,281
-86% -$657K 0.01% 926
2018
Q4 		$857K Buy
+74,673
New +$928K 0.05% 461
2018
Q2 		– Sell
-27,862
Closed -$529K – 1171
2018
Q1 		$529K Buy
27,862
+2,072
+8% +$44.3K 0.04% 612
2017
Q4 		$423K Buy
+25,790
New +$384K 0.05% 581
2017
Q3 		– Sell
-82,478
Closed -$726K – 1005
2017
Q2 		$726K Buy
+82,478
New +$529K 0.2% 138
2016
Q4 		– Sell
-15,952
Closed -$74K – 1119
2016
Q3 		$74K Buy
+15,952
New +$81.1K 0.02% 699
2016
Q2 		– Sell
-36,687
Closed -$222K – 1071
2016
Q1 		$222K Buy
+36,687
New +$220K 0.03% 819
2015
Q2 		– Sell
-36,100
Closed -$566K – 1213
2015
Q1 		$566K Sell
36,100
-47,858
-57% -$740K 0.06% 645
2014
Q4 		$1.28M Buy
+83,958
New +$1.02M 0.23% 83

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Trexquant Investment's SGMO Position: Q4 2020 in Review

Trexquant Investment sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2020, closing a stake of 148,502 shares — an estimated $1.4M sold.

Trexquant Investment first reported a position in SGMO in Q4 2014 and held it in 11 quarters. The position peaked at $1.4M in Q3 2020. 223 funds tracked by Wall St. Rank hold SGMO as of Q4 2020.

  • Trexquant Investment reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2020 after selling out during the quarter.
  • Trexquant Investment sold 148,502 SANGAMO THERAPEUTICS INC shares in Q4 2020, an estimated $1.4M.
  • Trexquant Investment first reported a position in SANGAMO THERAPEUTICS INC in Q4 2014 and held it in 11 quarters.
  • Trexquant Investment's SANGAMO THERAPEUTICS INC position peaked at $1.4M in Q3 2020.
  • 223 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2020.

Based on Trexquant Investment's 13F filing for Q4 2020, filed 11 Feb 2021.